Karsten Lindhardt
10Patents
5h-index
17Co-inventors
59Inventor score
Filing activity: Feb 5, 2010 → Aug 18, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8603526B2 | Pharmaceutical compositions resistant to abuse | Human Necessities | 18 | Active |
| US8563038B2 | Formulations and methods for the controlled release of active drug substances | Human Necessities | 15 | Active |
| US9044402B2 | Abuse-deterrent pharmaceutical compositions for controlled release | Human Necessities | 14 | Active |
| US9168228B2 | Pharmaceutical compositions resistant to abuse | Human Necessities | 13 | Active |
| US9023394B2 | Formulations and methods for the controlled release of active drug substances | Human Necessities | 5 | Active |
| US11452851B2 | Oral delivery of active drug substances | Human Necessities | 1 | Active |
| US9498446B2 | Pharmaceutical compositions resistant to abuse | Human Necessities | 1 | Active |
| US12070566B2 | Oral delivery of active drug substances | Human Necessities | 0 | Active |
| US9549899B2 | Abuse deterrent pharmaceutical compositions for controlled release | Human Necessities | 0 | Active |
| US10105321B2 | Pharmaceutical compositions resistant to abuse | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.